Best of Hematology and Breast Cancer™ 2026, Nashville conference hero image

Best of Hematology and Breast Cancer™ 2026, Nashville

Accreditation: 7.25 ACPE Pharmacy | 7.25 Nursing Contact Hours | 7.25 ABIM MOC II | 7.25 AMA PRA Category 1 Credit™

Venue: Sheraton Grand Nashville Downtown, 623 Union St, Nashville, TN, United States

Start Date: End Date:
Register for Conference

Official conference page for Best of Hematology and Breast Cancer™ 2026, Nashville.

About Best of Hematology and Breast Cancer™ 2026, Nashville

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Muhamed Baljevic
30+

Faculty and committee

Conference program and agenda

Our Agenda

Day 1: Friday, February 6th, 2026

All timings are in Central Time (CDT, GMT-05:00) time.

02:30 PM - 03:30 PMRegistration, Networking, & Exhibits ( Ballroom Foyer & Ballroom 2/3 )
03:30 PM - 05:00 PMSession 1: Benign Hematology (Ballroom 4)

Session Chair: Michelle Chi, MD

03:30 PM - 04:00 PM

Clotting Disorders Deva Sharma, MD

04:00 PM - 04:15 PM

Bleeding Disorders Michelle Chi, MD

04:15 PM - 04:45 PM

Updates in the management of Anemia Katherine Walsh, MD

04:45 PM - 05:00 PM

Updates in PNH / HUS / TTP Miriam Brown, DO

Day 2: Saturday, February 7th, 2026

07:00 AM - 08:00 AMRegistration, Exhibits & Breakfast ( Ballroom Foyer & Ballroom 2/3 )
08:00 AM - 08:05 AMWelcome (Ballroom 4)
08:05 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Care Disparities (Ballroom 4) - Justin Marquart, MBA
08:30 AM - 09:30 AMSession 2: AML/MDS ( Ballroom 4)

Session Chair: Kateryna Fedorov, MD

08:30 AM - 09:00 AM

Menin inhibitors in acute Leukemias Kateryna Fedorov, MD

09:00 AM - 09:30 AM

MDS/MPN Updates 2025 Ashwin Kishtagari, MD

09:30 AM - 10:45 AMSession 3: Multiple Myeloma ( Ballroom 4 )

Session Chair: Muhamed Baljevic, MD

09:30 AM - 09:55 AM

Updates in TE and TIE NDMM Phyu Naing, MD

09:55 AM - 10:20 AM

Treatment approaches in early RRMM Noura Elsedawy, MD

10:20 AM - 10:45 AM

Treatment approaches in late RRMM Salyka Sengsayadeth, MD

10:45 AM - 11:00 AMBreak & Exhibits (Ballroom 2/3)
11:00 AM - 12:00 PMSession 4: Lymphoma ( Ballroom 4)

Session Chair: Vivek Patel, MD

11:00 AM - 11:30 AM

Updates in the management of High-grade and large cell lymphomas Elisa De Togni, MD

11:30 AM - 12:00 PM

Updates in the management of indolent Lymphomas Vivek Patel, MD

12:00 PM - 01:00 PMLunch & Exhibits (Ballroom 2/3) - Product Theater sponsored by Kura (non-CME accredited): Managing KOMZIFTI in Patients With R/R NPM1-m AML - Dr. James McCloskey ( Ryman Meeting Room)
01:00 PM - 02:20 PMSession 5: Metastatic Breast Cancer ( Ballroom 4)

Session Chair: Erika Hamilton, MD

01:00 PM - 01:20 PM

Novel Backbones and Combinations in Metastatic HR+ Breast Sarah Premji, MD

01:20 PM - 01:40 PM

Debate: DB-09 vs. DB-03 for HER-2+ Breast Sonya Reid, MD

01:40 PM - 02:00 PM

Debate 2: DB-09 vs. DB-03 for HER-2+ Breast Gregory Vidal, MD, PhD

02:00 PM - 02:20 PM

Novel ADCs for metastatic HR+ and TNBC Erika Hamilton, MD

02:20 PM - 02:30 PMBreak & Exhibits (Ballroom 2/3)

Venue and map

Accreditations and continuing education

Acknowledgement of Commerical Support

This activity is supported with Independent Medical Education grants from:

  • Gilead
  • Stemline Therapeutics, Inc

Accreditation

Registration and pricing

Exhibitors and sponsorship